Color Genomics has received a certificate of accreditation from the College of American Pathologists (CAP) following inspection of our clinical laboratory facility in Burlingame, CA. In order to receive CAP accreditation, a laboratory must demonstrate that it operates with the highest standards of quality, accuracy and consistency. The CAP inspection process investigates several components of the laboratory: assay validation data, quality management program, sample tracking procedures, lab personnel qualifications, facilities, safety, and having a lab that is compliant and ready for inspection. As a laboratory focused on democratizing access to high-quality genetic information in a responsible manner, we are proud that our commitment to quality has been recognized by the gold standard in laboratory accreditation programs.
“We’re proud to obtain this accreditation from CAP,” said Dianne Keen-Kim, Ph.D., FACMG, Laboratory Director at Color Genomics. “This recognition demonstrates Color’s unwavering commitment to applying the highest quality testing standards and returning results of exceptional quality, accuracy and reliability.”
The CAP Laboratory Accreditation Program is an internationally recognized program designed to help clinical labs achieve excellence beyond that which is required for regulatory compliance. The goal of the CAP accreditation program is to increase the value that laboratories bring to individuals. The CAP program does this by holding laboratories to a high standard of scientific rigor, accuracy, reliability and consistent quality. Because of its comprehensive nature, the Centers for Medicare & Medicaid Services (CMS) has granted the CAP Laboratory Accreditation Program deeming authority to inspect and accredit clinical laboratories. The program is also recognized by the Joint Commission, and can be used to meet many state as well as international certification requirements.
Color Genomics’ high standards of quality also led to CLIA (Clinical Laboratory Improvement Amendments) certification. In addition, Color was selected as the genomics partner for the multi-year $14.1 million-funded University of California Athena WISDOM study on personalized breast cancer screening. Our mission is to provide high-quality genetic information for breast and ovarian cancer risk to everyone and we are proud to be officially CAP-accredited.
CAP #: 8975161
CLIA #: 05D2081492